JP2024514956A5 - - Google Patents

Info

Publication number
JP2024514956A5
JP2024514956A5 JP2023565273A JP2023565273A JP2024514956A5 JP 2024514956 A5 JP2024514956 A5 JP 2024514956A5 JP 2023565273 A JP2023565273 A JP 2023565273A JP 2023565273 A JP2023565273 A JP 2023565273A JP 2024514956 A5 JP2024514956 A5 JP 2024514956A5
Authority
JP
Japan
Prior art keywords
aav
acid sequence
amino acid
capsid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565273A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024514956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/026048 external-priority patent/WO2022226374A1/en
Publication of JP2024514956A publication Critical patent/JP2024514956A/ja
Publication of JP2024514956A5 publication Critical patent/JP2024514956A5/ja
Pending legal-status Critical Current

Links

JP2023565273A 2021-04-23 2022-04-22 組織標的化された改変aavカプシドおよびその使用方法 Pending JP2024514956A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163178965P 2021-04-23 2021-04-23
US63/178,965 2021-04-23
US202263299697P 2022-01-14 2022-01-14
US63/299,697 2022-01-14
PCT/US2022/026048 WO2022226374A1 (en) 2021-04-23 2022-04-22 Tissue-targeted modified aav capsids and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024514956A JP2024514956A (ja) 2024-04-03
JP2024514956A5 true JP2024514956A5 (cg-RX-API-DMAC7.html) 2026-03-17

Family

ID=81598018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565273A Pending JP2024514956A (ja) 2021-04-23 2022-04-22 組織標的化された改変aavカプシドおよびその使用方法

Country Status (5)

Country Link
US (1) US20240197918A1 (cg-RX-API-DMAC7.html)
EP (1) EP4326868A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024514956A (cg-RX-API-DMAC7.html)
CA (1) CA3216419A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022226374A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12668814B2 (en) * 2020-07-22 2026-06-30 The Broad Institute, Inc. Engineered muscle targeting compositions
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
EP4353737A1 (en) * 2022-10-10 2024-04-17 Universitätsklinikum Hamburg-Eppendorf Fusion proteins comprising a cell surface marker specific vhh
JP2026509271A (ja) 2023-03-10 2026-03-17 ダイノ セラピューティクス,インコーポレーテッド カプシドポリペプチドおよびその使用方法
CN118955652A (zh) * 2023-05-15 2024-11-15 杭州新昶基因技术有限公司 腺相关病毒衣壳蛋白、包含其的腺相关病毒及应用
AU2024271851A1 (en) * 2023-05-16 2025-12-18 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
WO2025137378A1 (en) * 2023-12-20 2025-06-26 Aavantibio, Inc. Aav capsid engineering for cardiac and/or musculoskeletal gene therapy
WO2025133247A1 (en) * 2023-12-21 2025-06-26 Genethon Methods for aav vector re-administration
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2025185625A1 (zh) * 2024-03-04 2025-09-12 苏州新芽基因生物技术有限公司 特异性靶向人组织的多肽序列及其在构建递送载体中的应用
TW202609054A (zh) * 2024-05-01 2026-03-01 日商Jcr製藥股份有限公司 經修飾之aav粒子、其製造方法、相關之醫藥及其製造方法
WO2026064428A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064444A1 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026069251A1 (en) * 2024-09-30 2026-04-02 Sarepta Therapeutics, Inc. Adeno-associated virus capsid antibodies and fragments thereof
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004514407A (ja) 2000-04-28 2004-05-20 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター
WO2006076024A2 (en) * 2004-05-14 2006-07-20 University Of Miami A method for targeting synapse with acetylcholinesterase
DE23193606T1 (de) * 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
CN101895633A (zh) 2010-07-14 2010-11-24 中兴通讯股份有限公司 一种移动终端及其解锁方法
US9580714B2 (en) 2010-11-24 2017-02-28 The University Of Western Australia Peptides for the specific binding of RNA targets
CA2826273C (en) * 2011-02-10 2021-11-02 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
ES2751126T3 (es) 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
US9434928B2 (en) 2011-11-23 2016-09-06 Nationwide Children's Hospital, Inc. Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
US10330674B2 (en) 2015-01-13 2019-06-25 Massachusetts Institute Of Technology Pumilio domain-based modular protein architecture for RNA binding
CN111936621B (zh) * 2018-02-05 2025-05-13 奥登茨治疗公司 转录调控元件和它的用途
CA3097375A1 (en) * 2018-04-27 2019-10-31 Universitat Heidelberg Modified aav capsid polypeptides for treatment of muscular diseases
AU2020299026A1 (en) * 2019-07-04 2022-01-20 Children's Medical Research Institute Methods and AAV vectors for in vivo transduction
JP2022551986A (ja) * 2019-10-16 2022-12-14 ザ・ブロード・インスティテュート・インコーポレイテッド 修飾筋肉標的化組成物
US20230193316A1 (en) * 2020-05-01 2023-06-22 The Broad Institute, Inc. Engineered central nervous system compositions
WO2022020616A1 (en) * 2020-07-22 2022-01-27 The Broad Institute, Inc. Engineered muscle targeting compositions

Similar Documents

Publication Publication Date Title
JP7374119B2 (ja) 減少した肝臓向性を有するAAV9とAAVrh74とのハイブリッド組換えアデノ随伴ウイルス血清型
US20240197918A1 (en) Tissue-targeted modified aav capsids and methods of use thereof
JP2023534999A5 (cg-RX-API-DMAC7.html)
CN116096431A (zh) 肽修饰的aav衣壳
Vandenberghe et al. Tailoring the AAV vector capsid for gene therapy
JP2022551986A5 (cg-RX-API-DMAC7.html)
Colon-Thillet et al. Optimization of AAV vectors to target persistent viral reservoirs
IL273261B2 (en) Adeno-associated virus variant capsids and methods of using them
JP2022526018A5 (cg-RX-API-DMAC7.html)
JP2023524061A5 (cg-RX-API-DMAC7.html)
JP2023537625A5 (cg-RX-API-DMAC7.html)
JP2020513811A5 (cg-RX-API-DMAC7.html)
JP2022547197A5 (cg-RX-API-DMAC7.html)
JP2025515979A5 (cg-RX-API-DMAC7.html)
CN116209768A (zh) 用于通过高变区交换工程化新杂合aav衣壳的方法
JP2023514242A5 (cg-RX-API-DMAC7.html)
WO2023060269A4 (en) Recombinant adeno-associated viruses for targeted delivery
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2022541070A5 (cg-RX-API-DMAC7.html)
JP2025500347A5 (cg-RX-API-DMAC7.html)
CN113748122A (zh) 具有脑靶向特性的aav突变体
CN119403823A (zh) 具有增强的肌肉转导效率的肽修饰的aav衣壳
JP2021534766A5 (cg-RX-API-DMAC7.html)
JP2024515626A5 (cg-RX-API-DMAC7.html)
JP2022531892A5 (cg-RX-API-DMAC7.html)